scholarly journals Early treatment of rituximab combined with eltrombopag for secondary thrombocytopenic purpura in rheumatoid arthritis

Medicine ◽  
2022 ◽  
Vol 101 (2) ◽  
pp. e28417
Author(s):  
Naidan Zhang ◽  
Chaixia Ji ◽  
Xiao Bao ◽  
Chengliang Yuan
Keyword(s):  
Rheumatoid Arthritis ◽  
Early Treatment ◽  
Thrombocytopenic Purpura

scholarly journals A Case of Rheumatoid Arthritis Accompanied by Thrombotic Thrombocytopenic Purpura

2015 ◽  
Vol 89 (1) ◽  
pp. 122
Author(s):  
Sung Min Kang ◽  
Ji Hyun Lee ◽  
In Hye Ku ◽  
Hae Koo Kim ◽  
Kyoung Sik Nam ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Thrombotic Thrombocytopenic Purpura ◽  
Thrombocytopenic Purpura

scholarly journals THROMBOCYTOPENIC PURPURA COMPLICATING GOLD THERAPY FOR RHEUMATOID ARTHRITIS

Blood ◽  
1948 ◽  
Vol 3 (10) ◽  
pp. 1105-1111 ◽  
Author(s):  
STACY R. METTIER ◽  
ALICE Mc BRIDE ◽  
JONAH LI
Keyword(s):  
Rheumatoid Arthritis ◽  
Blood Platelets ◽  
Spontaneous Remission ◽  
Gold Salt ◽  
Gold Therapy ◽  
Thrombocytopenic Purpura ◽  
Fourth Patient ◽  
Dramatic Rise ◽  
Hemorrhagic Tendency

Abstract Of 160 patients treated with gold salt therapy, four developed thrombocytopenia with mild purpuric manifestations. In three patients there was a spontaneous remission and the hemorrhagic tendency disappeared in about one week’s time. In the fourth patient there was a second occurrence of thrombocytopenia which persisted over a period of four months, and finally failed to respond to transfusions. Splenectomy was followed by a dramatic rise in the blood platelets and recovery of the patient.

scholarly journals Autoantibody status is not associated with early treatment response to first-line methotrexate in patients with early rheumatoid arthritis

Rheumatology ◽  
2018 ◽  
Vol 58 (1) ◽  
pp. 149-153 ◽  
Author(s):  
Jacqueline S Dekkers ◽  
Sytske Anne Bergstra ◽  
Arvind Chopra ◽  
Mohammed Tikly ◽  
João Eurico Fonseca ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Treatment Response ◽  
Early Rheumatoid Arthritis ◽  
Early Treatment ◽  
First Line ◽  
Early Treatment Response ◽  
Autoantibody Status
Sign in / Sign up

Export Citation Format

Share Document